Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

IFN-α and CD46 stimulation are associated with active lupus and skew natural T regulatory cell differentiation to type 1 regulatory T (Tr1) cells.

Le Buanec H, Gougeon ML, Mathian A, Lebon P, Dupont JM, Peltre G, Hemon P, Schmid M, Bizzini B, Künding T, Burny A, Bensussan A, Amoura Z, Gallo RC, Zagury D.

Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):18995-9000. doi: 10.1073/pnas.1113301108. Epub 2011 Nov 7.

2.

Modulation of the central memory and Tr1-like regulatory T cells in multiple sclerosis patients responsive to interferon-beta therapy.

Chiarini M, Serana F, Zanotti C, Capra R, Rasia S, Rottoli M, Rovaris M, Caputo D, Cavaletti G, Frigo M, Frigeni B, Clerici R, Rezzonico M, Caimi L, Imberti L.

Mult Scler. 2012 Jun;18(6):788-98. doi: 10.1177/1352458511427720. Epub 2011 Nov 15.

PMID:
22086901
3.

Suppression of allogeneic T cells proliferation by CD3/CD46-induced T-regulatory 1 cells.

Chen D, Zhang Y, Li M, Zhang C, Chen G, Chen Z, Chen S, Zhang W.

J Huazhong Univ Sci Technolog Med Sci. 2010 Jun;30(3):332-6. doi: 10.1007/s11596-010-0352-5. Epub 2010 Jun 17.

PMID:
20556577
4.

T-cell regulation by CD46 and its relevance in multiple sclerosis.

Astier AL.

Immunology. 2008 Jun;124(2):149-54. doi: 10.1111/j.1365-2567.2008.02821.x. Epub 2008 Apr 2. Review.

5.

Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis.

Astier AL, Meiffren G, Freeman S, Hafler DA.

J Clin Invest. 2006 Dec;116(12):3252-7. Epub 2006 Nov 9.

6.

Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype.

Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP.

Nature. 2003 Jan 23;421(6921):388-92.

PMID:
12540904
7.
8.

CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.

Ankathatti Munegowda M, Xu S, Freywald A, Xiang J.

Mol Immunol. 2012 Jun;51(2):143-9. doi: 10.1016/j.molimm.2012.02.120. Epub 2012 Mar 17.

PMID:
22424785
9.

Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys.

Ma A, Xiong Z, Hu Y, Qi S, Song L, Dun H, Zhang L, Lou D, Yang P, Zhao Z, Wang X, Zhang D, Daloze P, Chen H.

Int Immunopharmacol. 2009 May;9(5):599-608. doi: 10.1016/j.intimp.2009.01.034. Epub 2009 Feb 10.

PMID:
19539557
10.

Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.

Yan B, Ye S, Chen G, Kuang M, Shen N, Chen S.

Arthritis Rheum. 2008 Mar;58(3):801-12. doi: 10.1002/art.23268.

11.

Increased CD45RA+ FoxP3(low) regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus.

Pan X, Yuan X, Zheng Y, Wang W, Shan J, Lin F, Jiang G, Yang YH, Wang D, Xu D, Shen L.

PLoS One. 2012;7(4):e34662. doi: 10.1371/journal.pone.0034662. Epub 2012 Apr 10.

12.

CD46 engagement on human CD4+ T cells produces T regulatory type 1-like regulation of antimycobacterial T cell responses.

Truscott SM, Abate G, Price JD, Kemper C, Atkinson JP, Hoft DF.

Infect Immun. 2010 Dec;78(12):5295-306. doi: 10.1128/IAI.00513-10. Epub 2010 Oct 4.

13.

IL-6 produced by type I IFN DC controls IFN-gamma production by regulating the suppressive effect of CD4+ CD25+ regulatory T cells.

Detournay O, Mazouz N, Goldman M, Toungouz M.

Hum Immunol. 2005 May;66(5):460-8. Epub 2005 Feb 26.

PMID:
15935883
14.

Isolation, expansion and functional assessment of CD4+CD25+FoxP3+ regulatory T cells and Tr1 cells from uremic patients awaiting kidney transplantation.

Berglund D, Korsgren O, Lorant T, Schneider K, Tufveson G, Carlsson B.

Transpl Immunol. 2012 Jan;26(1):27-33. doi: 10.1016/j.trim.2011.09.003. Epub 2011 Sep 20.

PMID:
21958749
15.

Responses of CD4(+) CD25(+) Foxp3(+) and IL-10-secreting type I T regulatory cells to cluster-specific immunotherapy for allergic rhinitis in children.

Lou W, Wang C, Wang Y, Han D, Zhang L.

Pediatr Allergy Immunol. 2012 Mar;23(2):140-9. doi: 10.1111/j.1399-3038.2011.01249.x. Epub 2011 Dec 23.

PMID:
22192331
16.

CD46 processing: a means of expression.

Ni Choileain S, Astier AL.

Immunobiology. 2012 Feb;217(2):169-75. doi: 10.1016/j.imbio.2011.06.003. Epub 2011 Jul 13. Review.

17.

A defect of CD4+CD25+ regulatory T cells in inducing interleukin-10 production from CD4+ T cells under CD46 costimulation in asthma patients.

Xu YQ, Gao YD, Yang J, Guo W.

J Asthma. 2010 May;47(4):367-73. doi: 10.3109/02770903.2010.481340.

PMID:
20528588
18.

Regulatory T cells in patients with systemic lupus erythematosus.

Alvarado-Sánchez B, Hernández-Castro B, Portales-Pérez D, Baranda L, Layseca-Espinosa E, Abud-Mendoza C, Cubillas-Tejeda AC, González-Amaro R.

J Autoimmun. 2006 Sep;27(2):110-8. Epub 2006 Aug 4.

PMID:
16890406
19.

Functional defects of CD46-induced regulatory T cells to suppress airway inflammation in mite allergic asthma.

Tsai YG, Niu DM, Yang KD, Hung CH, Yeh YJ, Lee CY, Lin CY.

Lab Invest. 2012 Sep;92(9):1260-9. doi: 10.1038/labinvest.2012.86. Epub 2012 Jul 2.

20.

Revisiting regulatory T cells in type 1 diabetes.

Zhang Y, Bandala-Sanchez E, Harrison LC.

Curr Opin Endocrinol Diabetes Obes. 2012 Aug;19(4):271-8. doi: 10.1097/MED.0b013e328355a2d5. Review.

PMID:
22732485

Supplemental Content

Support Center